Abstract:Desmosomes are transmembrane protein complexes critical for cell-cell adhesion in epithelial tissues and other cell types. In skin cancers like melanoma, epithelial cells called keratinocytes are the predominant cells in the primary melanoma microenvironment, yet it remains largely unknown whether this cell type is subject to genetic alterations during melanoma development and its role in early melanoma progression. In this study, using an integrative analysis of tumor mutations and protein biophysical interactions, we identify a high frequency of genetic alterations in desmosome-related genes in human cancers, with the highest occurrences in cutaneous melanoma. Notably, over 70% of cutaneous melanoma cases exhibit mutations in desmosome genes and desmosome gene mutations are associated with lowered expression of the desmosome complex in melanoma. Using spatial transcriptomics and immunohistochemistry analyses, we find that the decrease in desmosome gene expression predominantly occurs in keratinocytes within the tumor microenvironment rather than in the melanoma cells themselves. To study the functional significance of this alteration in melanoma development, we used a human melanoma/keratinocyte co-culture system using primary melanoma cell lines. Our studies show that knockdown of desmosome genes in keratinocytes markedly increased proliferation of adjacent melanoma cells in melanoma/keratinocyte co-cultures. Additionally, melanoma cell proliferation is enhanced when exposed to media preconditioned by desmosome-deficient keratinocytes. These observations suggest that the gradual accumulation of mutations in desmosome genes within neighboring keratinocytes may create a conducive environment that primes melanoma cells for neoplastic transformation. This study underscores the critical role of genetic alterations in the tumor microenvironment in melanoma progression and highlights the potential for targeting desmosome-related pathways in therapeutic strategies against melanoma. Citation Format: Mohita Tagore. Desmosome mutations in the microenvironment regulate melanoma proliferation [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer; 2024 Nov 17-20; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2024;84(22_Suppl) nr A042.

Dangerous liaisons: Loss of keratinocyte control over melanocytes in melanomagenesis

Solar exposure, the melanocyte and melanoma: Survival pathways and molecular mechanisms.

Loss of 'Epidermal Melanin Unit' Integrity in Human Skin During Melanoma-Genesis

Contribution of Keratinocytes in Skin Cancer Initiation and Progression

The Keratinocyte in the Picture Cutaneous Melanoma Microenvironment

Cell Senescence and the Genetics of Melanoma Development

Current Insights into the Role of UV Radiation-Induced Oxidative Stress in Melanoma Pathogenesis

Melanocyte lineage dynamics in development, growth and disease

The journey from melanocytes to melanoma

Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression

Oxidative-Stress-Sensitive microRNAs in UV-Promoted Development of Melanoma

Genetics and epigenetics of melanoma

Abstract A042: Desmosome mutations in the microenvironment regulate melanoma proliferation

The role of altered nucleotide excision repair and UVB-induced DNA damage in melanomagenesis

Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment

Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship

The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies

Participation of keratinocyte‐ and fibroblast‐derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders

Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment

Roles of UVA radiation and DNA damage responses in melanoma pathogenesis

Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance